Literature DB >> 33741555

Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases.

Caoilfhionn M Connolly1, Jake A Ruddy2, Brian J Boyarsky2, Robin K Avery3, William A Werbel3, Dorry L Segev2,4, Jacqueline Garonzik-Wang2, Julie J Paik5.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; epidemiology; vaccination

Mesh：

Substances：

Year:  2021        PMID： 33741555     DOI： 10.1136/annrheumdis-2021-220231

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

Review 1.  Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.

Authors:  Pankti Mehta; Armen Yuri Gasparyan; Olena Zimba; George D Kitas
Journal:  Clin Rheumatol       Date:  2022-05-31       Impact factor: 3.650

Review 2.  A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.

Authors:  Farnoosh Seirafianpour; Homa Pourriyahi; Milad Gholizadeh Mesgarha; Arash Pour Mohammad; Zoha Shaka; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2022-04-11       Impact factor: 3.858

3.  Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.

Authors:  Francesca Romana Spinelli; Ennio Giulio Favalli; Fabrizio Conti; Roberto Caporali; Cristina Garufi; Martina Cornalba; Serena Colafrancesco
Journal:  Arthritis Res Ther       Date:  2022-01-11       Impact factor: 5.156

4.  Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.

Authors:  Ross S Greenberg; Jake A Ruddy; Brian J Boyarsky; William A Werbel; Jacqueline M Garonzik-Wang; Dorry L Segev; Philip H Imus
Journal:  BMC Cancer       Date:  2021-12-27       Impact factor: 4.430

Review 5.  Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.

Authors:  Christof Specker; Peer Aries; Jürgen Braun; Gerd Burmester; Rebecca Fischer-Betz; Rebecca Hasseli; Julia Holle; Bimba Franziska Hoyer; Christof Iking-Konert; Andreas Krause; Klaus Krüger; Martin Krusche; Jan Leipe; Hanns-Martin Lorenz; Frank Moosig; Rotraud Schmale-Grede; Matthias Schneider; Anja Strangfeld; Reinhard Voll; Anna Voormann; Ulf Wagner; Hendrik Schulze-Koops
Journal:  Z Rheumatol       Date:  2021-09-07       Impact factor: 1.372

6.  Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.

Authors:  Caoilfhionn M Connolly; Jake A Ruddy; Brian J Boyarsky; Iulia Barbur; William A Werbel; Duvuru Geetha; Jacqueline M Garonzik-Wang; Dorry L Segev; Lisa Christopher-Stine; Julie J Paik
Journal:  Arthritis Rheumatol       Date:  2021-12-03       Impact factor: 10.995

7.  Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.

Authors:  Laura Boekel; Laura Y Kummer; Koos P J van Dam; Femke Hooijberg; Zoé van Kempen; Erik H Vogelzang; Luuk Wieske; Filip Eftimov; Ronald van Vollenhoven; Taco W Kuijpers; S Marieke van Ham; Sander W Tas; Joep Killestein; Maarten Boers; Mike T Nurmohamed; Theo Rispens; Gertjan Wolbink
Journal:  Lancet Rheumatol       Date:  2021-06-18

8.  Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey.

Authors:  Somy Cherian; Aby Paul; Sakir Ahmed; Bazil Alias; Manesh Manoj; Ansu K Santhosh; Delcey Rachel Varghese; Narayanan Krishnan; Padmanabha Shenoy
Journal:  Rheumatol Int       Date:  2021-06-17       Impact factor: 2.631

9.  SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.

Authors:  Tina Ko; Claire Dendle; Ian Woolley; Eric Morand; Anna Antony
Journal:  Hum Vaccin Immunother       Date:  2021-08-06       Impact factor: 4.526

Review 10.  [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].

Authors:  Christof Specker; Peer Aries; Jürgen Braun; Gerd Burmester; Rebecca Fischer-Betz; Rebecca Hasseli; Julia Holle; Bimba Franziska Hoyer; Christof Iking-Konert; Andreas Krause; Klaus Krüger; Martin Krusche; Jan Leipe; Hanns-Martin Lorenz; Frank Moosig; Rotraud Schmale-Grede; Matthias Schneider; Anja Strangfeld; Reinhard Voll; Anna Voormann; Ulf Wagner; Hendrik Schulze-Koops
Journal:  Z Rheumatol       Date:  2021-08       Impact factor: 1.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.